Peri-operative blood management in elective orthopaedic surgery. A critical review of the literature

Injury

Volumn 37, Issue SUPPL. 5, 2006, Pages

  Moonen, A F C M ^a   Neal, T D ^b   Pilot, P ^c  

^a Atrium MC ^*  (Netherlands)

^b ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^c REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

Autologous donation; Blood loss; Epoetin; Haemoglobin; Transfusion

Indexed keywords

APROTININ; FIBRIN; HEMOGLOBIN; IRON; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT ERYTHROPOIETIN; TRANEXAMIC ACID;

ARTICLE; AWARENESS; BLEEDING; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BLOOD VOLUME; ELECTIVE SURGERY; EPIDURAL ANESTHESIA; HEMODILUTION; HEMOGLOBIN BLOOD LEVEL; HIP ARTHROPLASTY; HUMAN; KNEE ARTHROPLASTY; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; PLASMAPHERESIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RISK FACTOR; SURGICAL TECHNIQUE; THROMBOCYTE;

ANESTHESIA, EPIDURAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION, AUTOLOGOUS; EPOETIN ALFA; HEMODILUTION; HUMANS; ORTHOPEDIC PROCEDURES; SURGICAL PROCEDURES, ELECTIVE; TRANSPLANTATION, HOMOLOGOUS;

EID: 33847332986     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-1383(07)70006-2     Document Type: Article

References (62)

1. National Heart, Lung, and Blood Institute Expert Panal on the use of autologous blood. Transfusion alert: use of autologous blood. Transfusion 35 (1995) 703-711
2. Sazama K. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion 30 (1990) 583-590
3. Williamson L., and Lowe S. Serious hazards of transfusion (SHOT) initiative: analysis of the two annual reports. Br Med J 319 (1999) 16-19
4. Goodnough L., Shander A., and Brechner M. Transfusion medicine: Looking to the future. Lancet 361 (2003) 161-169
5. Goodnough L., and Shuck J. Risks, options, and informed consent for blood transfusion in elective surgery. Am J Surg 159 (1990) 602-609
6. Klein H. Allogeneic transfusion risks in the surgical patient. Am J Surg 170 (1995) 215-265
7. Dodd R. Current estimates of transfusion safety worldwide. Dev Biol (Basel) 120 (2005) 3-10
8. Wylie B. Transfusion transmitted infection: viral and exotic diseases. Anaesth Intens Care 21 (1993) 24-30
9. Bierbaum B., Callaghan J., Galante J., Rubash H., Tooms R., and Welch R. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 81 (1999) 2-10
10. Grzelak I., Zaleska M., and Olszewski W. Blood transfusions downregulate hematopoisis and subsequently downregulate the immune response. Transfusion 38 (1998) 1104-1141
11. Spence R., Cernaianu A., Carson J., and DelRossi A. Transfusion and surgery. Curr Prob Surg 30 (1993) 1112-1180
12. Tartter P. Immunologic effects of blood transfusion. Immunol Invest 24 (1995) 277-288
13. Hill G., Frawley W., Griffith K., Forestner J., and Minei J. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma 54 5 (2003) 908-914
14. Triulzi D., Blumbert N., and Heal J. Association of transfusion with postoperative bacterial infection. Crit Rev Clin Lab Sci 28 (1990) 95-107
15. Slappendel R., Dirksen R., Weber E., and van der Schaaf D. An algorithm to reduce allogeneic red blood cell transfusions for major orthopaedic surgery. Acta Orthop Scand 74 (2003) 569-575
16. Spence R. Surgical red blood cell transfusion practice policies. Blood management practice guidelines conference. Am J Surg 170 suppl (1995) 3-15
17. Ishii Y., and Matsuda Y. Effect of the timing of tourniquet release on perioperative blood loss associated with cementless total knee arthroplasty. A prospective randomized study. J Arthroplasty 20 8 (2005) 977-983
18. Jorn L., Lindstrand A., and Toksvig-Larsen S. Tourniquet release for hemostasis increases bleeding. A randomized study of 77 knee replacements. Acta Orthop Scand 70 (1999) 265-267
19. Southern E., Huo M., Mehta J., and Keggi K. Unwashed wound drainage blood. What are we giving our patients?. Clin Orthop 320 (1995) 235-246
20. Carson J., and Chen A. In search of the transfusion trigger. Clin Orthop Relat Res 357 (1998 Dec) 30-35
21. Pilot P., Moonen A., Stuart W., Bell C., Bogie R., Pinckaers J., et al. [Bloedverbruik aan banden.] Limited blood use; Success due to restrictive policy, education and awareness. Med Contact 60 37 (2005) 1467-1469
22. American Society of Anesthesiologist Task Force. Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists task force on blood component therapy. Anesthesiology 84 (1996) 732-747
23. Hoeft A., Wietasch J., Sonntag H., and Kettler D. [Theoretical limits of "permissive anemia"]. Zentralbl Chir 120 8 (1995) 604-613 Article in German.
24. Spence R. Emerging trends in surgical blood transfusion. Semin Hematol 34 (1997) 48-53
25. Eschbach J. Erythropoietin 1991 - an overview. Am J Kidney Dis 18 (1991) 3-9
26. Eschbach J. Iron requirements in erythropoietin therapy. Best Pract Res Clin Haematol 18 2 (2005) 347-361
27. Weber E., Slappendel R., Hemon Y., Mahler S., Dalen T., Rouwet E., et al. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 22 4 (2005 Apr) 249-257
28. de Andrade J., Jove M., Landon G., Frei D., Guilfoyle M., and Young D. Baseline haemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop 25 (1996) 533-542
29. Fan's P., and Ritter M. Epoetin alfa. A bloodless approach for the treatment of perioperative anemia. Clin Orthop 357 (1998) 60-67
30. Goldberg M., McCutchen J., Jove M., Di Cesare P., Friedman R., Poss R., et al. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 25 (1996) 544-552
31. Goodnough L., and Monk T. Erythropoietin therapy in the perioperative setting. Clin Orthop 357 (1998) 82-88
32. Slappendel R., Weber E., Hemon Y., Mahler S., Dalen T., Rouwet E., et al. Patients with and without rheumatoid arthritis benefit equally from preoperative epoetin alfa treatment. Acta Orthop 77 4 (2006 Aug) 677-683
33. Aufricht C., Ties M., Salzer-Muhar U., Wimmer M., Herkner K., and Haschke F. Erythropoietin, erythropoesis and iron status in children after major surgical stress. Eur J Pediatr 154 6 (1995) 458-461
34. Biesma D., Van de Wiel A., Beguin Y., Kraaijenhagen R., and Marx J. Postoperative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. Eur JClin Invest 25 (1995) 383-389
35. van Iperen C., Kraaijenhagen R., Biesma D., Beguins Y., Marx J., and van de Wiel A. Iron metabolism and erythropoiesis after surgery. Brit J Surg 85 (1988) 41-45
36. Madi-Jebara A., Sleilaty G., Achouh P., Yazigi A., Haddead F., Hayek G., et al. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. J Cardiothorac Vase Anesth 18 1 (2004) 59-63
37. Healy J., Frankfurter S., Graves B., Reddy R., and Beck J. Preoperative autologous blood donation in total-hip arthroplasty. A cost-effectiveness analysis. Arch Pathol and LabMed 118 (1994) 465-470
38. Woolson S., and Pottorff G. Use of preoperatively deposited autologous blood for total knee replacement. Orthopedics 16 (1993) 137-141
39. Woolson S., and Watt J. Use of autologous blood in total hip replacement. A comprehensive program. J Bone Joint Surg 73-A (1991) 76-80
40. Goldman M., Remy-Prince S., Trepanier A., and Decary F. Autologous donation error rates in Canada. Transfusion 37 5 (1997) 523-527
41. Goudnough L., Monk T., Despotis G., and Merkel K. A randomized trial of acute normovolemic hemodilution compared with preoperative autologous blood donation in total knee arthroplasty. Vox Sang 77 (1999) 11-16
42. Olsfanger D., Fredman B., Goldstein B., Shapiro A., and Jedeikin R. Acute normovolaemic haemodilution decreases postoperative allogeneic blood transfusion after total knee replacement. Br J Anaesth 79 3 (1997) 317-321
43. Gillon J., Thomas M., and Desmond M. Consensus conference on autologous transfusion. Acute normovolaemic haemodilution. Transfusion 36 (1996) 640-643
44. Cina C., It S., Clase C., and Bruin G. A cohort study of coagulation parameters and the use of blood products in surgery of the thoracic and thoracoabdominal aorta. J Vase Surg 33 (2001) 462-468
45. Slappendel R., Weber E., Benraad B., Dirksen R., and Bugter M. Does ibuprofen increase perioperative blood loss during hip arthroplasty?. Eur J Anaesthesiol 19 (2002) 829-831
46. Weber E., Slappendel R., Durieux M., Dirksen R., van der Heide H., and Spruit M. COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam. Eur J Anaesthesiol 20 12 (2003) 963-966
47. Ruel M., and Rubens F. Non-pharmacological strategies for blood conservation in cardiac surgery. Review. Can J Anaesth 48 4 Suppl (2001) S13-S23
48. Triulzi D., Gilmor G., Ness P., Baumgartner W., and Schultheis L. Efficacy of autologous fresh whole blood or platelet-rich plasma in adult cardiac surgery. Transfusion 35 8 (1995) 627-634
49. Levy O., and Martinowitz U. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after TKA. A prospective randomized multicenter study. J Bone Joint Surg 81A 11 (1999) 1580-1588
50. Radosevick M., and Goubran M. Fibrin sealant: scientific rationale, production methods, properties, and current clinical use. Review. Vox Sang 72 3 (1997) 133-143
51. Fritz H., and Wunderer G. Biochemistry and applications of aprotinin, the kalikrein inhibitor from bovine organs. Arzneimittel-Forschung 33 4 (1983) 479-494
52. Royston D. Aprotinin versus lysine analogues: the debate continues. Ann Thorac Surg 65 4 (1998) S9-S19
53. Niemi T., Pitkanen M., Syrjala M., and Rosenberg P. Comparison of hypotensive epidural anaesthesia and spinal anaesthesia on blood loss and coagulation during and after total hip arthroplasty. Acta Anaesthesiol Scand 44 4 (2000) 457-464
54. Eroglu A., Uzunlar H., and Erciyes N. Comparison of hypotensive epidural anesthesia and hypotensive total intravenous anesthesia on intraoperative blood loss during total hip replacement. J Clin Anesth 17 6 (2005) 420-425
55. Juelsgaard P., Larsen U., Sorensen J., Madsen F., and Soballe K. Hypotensive epidural anesthesia in total knee replacement without tourniquet: reduced blood loss and transfusion. Reg Anesth Pain Med 26 2 (2001) 105-110
56. Sharrock N., Beksac B., Flynn E., Go G., and Delia Valle A. Hypotensive epidural anaesthesia in patients with preoperative renal dysfunction undergoing total hip replacement. Br J Anaesth 96 2 (2006) 207-212
57. Tenholder M., and Cushner F. Intraoperative blood management in joint replacement surgery. Orthopedics 27 6 Suppl (2004) S663-S668
58. Elewad A., Ohlin A., Berntorp E., Nilsson I., and Fredin H. Intraoperative autotransfusion in primary hip arthroplasty. A randomized comparison with homologous blood. Acta Orthop Scand 62 6 (1991) 557-562
59. Cheng S., Hung T., and Tse P. Investigation of the use of drained blood reinfusion after total knee arthroplasty: A prospective randomised controlled study. J Orthop Surg 13 2 (2005) 120-124
60. Moonen A., Pilot P., Knoors N., van Os J., and Verburg A. A randomised clinical trial of filtered shed blood in primary hip and knee arthroplasty. Ned Tijdschr Orth 2 12 (2005) 113 Abstract.
61. Strumper D., Weber E., Gielen-Wijffels S., Van Drumpt R., Bulstra S., Slappendel R., et al. Clinical efficacy of postoperative autologous transfusion of filtered shed blood in hip and knee arthroplasty. Transfusion 44 (2004) 1567-1571
62. Han C., and Shin D. Postoperative blood salvage and reinfusion after total joint arthroplasty. J Arthroplasty 12 (1997) 511-516